- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 498/00 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patent holdings for IPC class C07D 498/00
Total number of patents in this class: 164
10-year publication summary
|
2
|
2
|
6
|
6
|
5
|
7
|
4
|
6
|
10
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4795 |
8 |
| Merck Sharp & Dohme Corp. | 2186 |
5 |
| Amgen Inc. | 4304 |
5 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 727 |
5 |
| Salix Pharmaceuticals, Ltd. | 46 |
5 |
| Merck Sharp & Dohme LLC | 3741 |
4 |
| SpecGx LLC | 186 |
3 |
| Cyclenium Pharma Inc. | 11 |
3 |
| The Regents of the University of California | 20410 |
2 |
| Genentech, Inc. | 4045 |
2 |
| Wyeth LLC | 636 |
2 |
| Merck Patent GmbH | 5729 |
2 |
| Merck Sharp & Dohme B.V. | 797 |
2 |
| Abbvie Inc. | 1828 |
2 |
| Astellas Pharma Inc. | 1049 |
2 |
| Exonhit Therapeutics SA | 23 |
2 |
| Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. | 59 |
2 |
| Medshine Discovery Inc. | 595 |
2 |
| Progenics Pharmaceuticals, Inc. | 131 |
2 |
| Rutgers, The State University of New Jersey | 1956 |
2 |
| Other owners | 102 |